Understanding proteasome assembly and regulation: importance to cardiovascular medicine.

Trends in Cardiovascular Medicine
Glen W YoungPeipei Ping

Abstract

The cardiac proteasome is increasingly recognized as a complex, heterogeneous, and dynamic organelle contributing to the modulation of cardiac function in health and diseases. The emerging picture of the proteasome system reveals a highly regulated and organized molecular machine integrated into multiple biologic processes of the cell. Full appreciation of its cardiovascular relevance requires an understanding of its proteolytic function as well as its underlying regulatory mechanisms, of which assembly, stoichiometry, posttranslational modification, and the role of the associating partners are increasingly poignant.

References

May 29, 2001·The Journal of Biological Chemistry·A L BulteauL I Szweda
Jun 14, 2002·Cardiovascular Research·Hartmut LüssJoachim Neumann
Oct 11, 2002·Proceedings of the National Academy of Sciences of the United States of America·Dietmar M W ZaissAlice J A M Sijts
Apr 24, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Xin DongXuejun Wang
Dec 2, 2004·Biochimica Et Biophysica Acta·Peter-M Kloetzel
Oct 6, 2005·Biological Chemistry·Marion SchmidtDaniel Finley
Jul 22, 2006·Circulation Research·Chenggong ZongPeipei Ping
Jul 22, 2006·Circulation Research·Aldrin V GomesPeipei Ping
Mar 21, 2007·Circulation·Cam PattersonMonte S Willis
Jun 15, 2007·The Journal of Biological Chemistry·Fengxue ZhangJeffrey E Kudlow
Jul 31, 2007·Molecular & Cellular Proteomics : MCP·Oliver DrewsPeipei Ping
Oct 3, 2007·Journal of Molecular Evolution·Gertrud Mannhaupt, Horst Feldmann
Oct 16, 2007·Molecular & Cellular Proteomics : MCP·Xiaorong Wang, Lan Huang

❮ Previous
Next ❯

Citations

Oct 22, 2008·Molecular & Cellular Proteomics : MCP·Aldrin V GomesPeipei Ping
Feb 5, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Xiaoping JiangKrista L Moulder
Nov 26, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jie LiXuejun Wang
Jul 1, 2009·Cardiovascular Research·Alexander KlossBurkhardt Dahlmann
Aug 18, 2009·Cardiovascular Research·Osamu TsukamotoMasafumi Kitakaze
Sep 12, 2009·Cardiovascular Research·Xichun Yu, David C Kem
Sep 18, 2009·Basic Research in Cardiology·Antje VoigtAlexander Staudt
Mar 26, 2010·Basic Research in Cardiology·Antje VoigtAlexander Staudt
Sep 16, 2010·Biochimica Et Biophysica Acta·Yi-Fan Li, Xuejun Wang
Dec 23, 2008·Current Opinion in Pharmacology·Xichun YuDavid C Kem
Aug 21, 2012·Circulation Research·Christopher C Glembotski
Mar 30, 2013·Circulation Research·Julia PaganAntonio Cittadini
Jan 12, 2012·International Journal of Public Health·Atif KukaswadiaWilliam Pickett
Dec 12, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Justine Calise, Saul R Powell
Feb 14, 2012·Experimental Biology and Medicine·Balindiwe J N SishiAnna-Mart Engelbrecht
Jun 5, 2013·American Journal of Physiology. Heart and Circulatory Physiology·Viswanathan RajagopalanDaniel Bernstein
Jul 3, 2021·International Journal of Molecular Sciences·Jun GotoMasafumi Watanabe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.